Inclusion Criteria:

- Patients older than 16 years

- Histologically-proven disseminated (non stage I) NSGCT, or diagnosis of NSGCT based
on very elevated serum human chorionic gonadotropin (HCG) and/or alpha fetoprotein
(AFP)

- Relapsed disease classified as good prognosis according to the Memorial
Sloan-Kettering Cancer Center (MSKCC) classification criteria:

- Testicular primary site

- Prior treatment limited to one program (or 6 or fewer cycles of cisplatin)

- Either a complete response or a partial response with normal serum AFP and HCG

- Relapse documented by rising AFP and/or HCG or by a biopsy

- No previous carcinoma, except basal-cell carcinoma of the skin

- Adequate renal function: measured or calculated creatinine clearance> 60 ml/min

- Absolute granulocyte count >= 1,500/mm3, platelets >= 100,000 mm3, bilirubin < 1.5
fold the upper normal value

- Signed informed consent.

Exclusion Criteria:

- Patients infected by the human immunodeficiency virus (HIV)

- Patients who do not fit inclusion criteria